1. Zonov E., Kochneva G., Yunusova A., Grazhdantseva A., Richter V., Ryabchikova E. Features of the antitumor effect of vaccinia virus Lister strain. Viruses. 2016, 8 (1), 20. doi: 10.3390/v8010020 https://pubmed.ncbi.nlm.nih.gov/26771631/
2. Shvalov A.N.., Sivolobova G.F., Kuligina E.V., Kochneva G.V. Complete Genome Sequence of Vaccinia Virus Strain L-IVP. Genome Announcements, 2016 Volume 4 Issue 3 e00372-16. DOI: 10.1128/genomeA.00372-16. https://www.researchgate.net/publication/303029888_Complete_Genome_Sequence_of_Vaccinia_Virus_Strain_L-IVP
3. Kochneva G., Sivolobova G., Tkacheva A., Grazhdantseva A., Troitskaya O.S., Nushtaeva A.A., Tkachenko A.V., Kuligina E.V., Richter V.A., Koval O.A. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy. Oncotarget, 2016, V. 7, N 45, P. 74171-74188. DOI 10.18632/oncotarget.12367. https://pubmed.ncbi.nlm.nih.gov/27708236/
4. A. A. Grazhdantseva, G. F. Sivolobovaa, A. V. Tkacheva, I. P. Gileva, E. V. Kuligina, V. A. Rikhter, and G. V. Kochneva. Highly Effective Production of Biologically Active, Secreted, Human Granulocyte-Macrophage Colony-Stimulating Factor by Recombinant Vaccinia Virus. Applied Biochemistry and Microbiology, 2016, Vol. 52, No. 7, pp. 7–13. https://link.springer.com/article/10.1134/S0003683816070036
5. Г.В. Кочнева, А.В. Ткачева, Г.Ф. Сиволобова, А.А.Гражданцева, А.Ю. Юнусова, Е.И. Рябчикова, Е.В. Кулигина, О.А. Коваль, В.А. Рихтер Противоопухолевый потенциал рекомбинантного штамма вируса осповакцины, продуцирующего секретируемый химерный белок, состоящий из гранулоцитарно-макрофагального колониестимулирующего фактора человека и онкотоксического белка лактаптина Биофармацевтический журнал, 2017, Т.9, № 1 http://www.niboch.nsc.ru/lib/exe/fetch.php/ru/intranet/icbfm-2017_lbt_.pdf
6. Koval O, Kochneva G, Tkachenko A, Troitskaya O, Sivolobova G, Grazhdantseva A, Nushtaeva A, Kuligina E, Richter V. Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells. Biomed Res Int. 2017. doi: 10.1155/2017/3620510. https://pubmed.ncbi.nlm.nih.gov/28951871/
7. G.V. Kochneva, O.A. Koval, E.V. Kuligina, A.V. Tkacheva and V.A. Richter Antitumor Effect of Vaccinia Virus Double Recombinant Strains Expressing Genes of Cytokine GM-CSF and Oncotoxic Peptide Lactaptin. Proceedings of the Scientific-Practical Conference “Research and Development - 2016” K.V. Anisimov et al. (eds.), с.581-590 https://doi.org/10.1007/978-3-319-62870-7_61
8. Vasileva N.S., Ageenko A.B., Dmitrieva M.D., Richter V.A., Kuligina E.V. (2021). Tumor stem cells could promote glioblastoma sensitivity to oncolytic virus. FEBS Open Bio, 11: P-08. 1-29. doi.org/10.1002/2211-5463.13205. Опубликовано https://www.mdpi.com/1420-3049/26/21/6564
9. Vasileva, N.; Ageenko, A.; Dmitrieva, M.; Nushtaeva, A.; Mishinov, S.; Kochneva, G.; Richter, V.; Kuligina, E. Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma. Life 2021, 11, 1084. https://doi.org/10.3390/life11101084.